0001209191-19-018638.txt : 20190311
0001209191-19-018638.hdr.sgml : 20190311
20190311203252
ACCESSION NUMBER: 0001209191-19-018638
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190308
FILED AS OF DATE: 20190311
DATE AS OF CHANGE: 20190311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Andrews Audrey T.
CENTRAL INDEX KEY: 0001568933
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07293
FILM NUMBER: 19673713
MAIL ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TENET HEALTHCARE CORP
CENTRAL INDEX KEY: 0000070318
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 952557091
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
BUSINESS PHONE: 469-893-2200
MAIL ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-08
0
0000070318
TENET HEALTHCARE CORP
THC
0001568933
Andrews Audrey T.
1445 ROSS AVENUE
SUITE 1400
DALLAS
TX
75202
0
1
0
0
SVP and General Counsel
Common Stock
2019-03-08
4
M
0
7844
A
89170
D
Common Stock
2019-03-08
4
F
0
3009
27.17
D
86161
D
Common Stock
2019-03-08
4
M
0
9930
A
96091
D
Common Stock
2019-03-08
4
F
0
3809
27.17
D
92282
D
2016 March Restricted Stock Units
2019-03-08
4
M
0
7844
0.00
D
Common Stock
7844
0
D
2016 March Performance-Based Restricted Stock Units
2019-03-08
4
M
0
9930
0.00
D
Common Stock
9930
0
D
As previously reported, on March 10, 2016, the reporting person received a grant of 23,530 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the settlement of 7,843 shares of common stock. The second vesting date occurred on March 9, 2018 (the business day prior to the anniversary date, which fell on a weekend), resulting in the settlement of 7,843 shares of common stock. The third vesting date occurred on March 8, 2019 (the business day prior to the anniversary date, which fell on a weekend), resulting in the settlement of the remaining 7,844 shares of common stock, as shown in Table I.
Restricted stock units convert into common stock on a one-for-one basis.
Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
As previously reported, on March 10, 2016, the reporting person received a target grant of 23,530 performance-based restricted stock units that were subject to the Company's achievement of specified performance goals for the three year period that ended on December 31, 2018. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance goals were achieved in part, and 42.2% of the target grant was awarded; therefore, 9,930 restricted stock units vested on March 8, 2019 (the business day prior to the third anniversary of the date of grant, which fell on a weekend), resulting in the settlement of 9,930 shares of common stock, as shown in Table I.
Restricted stock units are settled in shares of the Company's common stock upon vesting.
Anthony L. Shoemaker, as Attorney-in-Fact for Audrey T. Andrews
2019-03-11